About this Research Topic
This research topic in Frontiers in Medicine offers a concise overview of the latest knowledge in the field of Photomedicine on therapeutic and preventive modalities, and UV pathogenesis of skin cancer. Photomedicine has revolutionized the treatment of inflammatory and neoplastic skin diseases over the last century since Niels Ryberg Finsen was awarded in 1903 the Nobel Prize "in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science". From then on, the field has moved on in leaps and bounds to expand phototreatment to many inflammatory as well as neoplastic skin diseases.
We aim to promote the field by giving the latest insights into Photomedicine’s therapeutic modalities and molecular mechanisms in treatment of diseases of the skin and beyond, as well as prevention from photodermatoses and carcinogenesis, as the dark sites of light. By engaging clinicians and scientists we intend to advance basic, clinical and translational research in the field of Photomedicine with its numerous facets.
We aim to promote the field by giving the latest insights into Photomedicine’s therapeutic modalities and molecular mechanisms in treatment of diseases of the skin and beyond, as well as prevention from photodermatoses and carcinogenesis, as the dark sites of light. By engaging clinicians and scientists we intend to advance basic, clinical and translational research in the field of Photomedicine with its numerous facets.
Keywords: Photomedicine, phototherapy, photodermatosis, photoprotection, phototreatment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
